Treasury rules throw $160B merger into doubt
BR>
Shares in Allergan are crashing premarket after the U.S. Treasury announced new rules that could dissuade Pfizer from finalizing its takeover of the Irish Botox maker.
Source: Treasury rules throw $160B merger into doubt
Posted April 5th, 2016 in Uncategorized.




